Merck KGaA (ETR:MRK)

Market Cap	51.87B
Revenue (ttm)	21.27B
Net Income (ttm)	2.96B
Shares Out	434.78M
EPS (ttm)	6.80
PE Ratio	17.55
Forward PE	14.37
Dividend	2.20 (1.84%)
Ex-Dividend Date	Apr 28, 2025

Volume	418,667
Average Volume	302,216
Open	118.90
Previous Close	118.85
Day's Range	118.70 - 119.95
52-Week Range	100.70 - 154.65
Beta	0.73
RSI	55.81
Earnings Date	Mar 5, 2026

About Merck KGaA

Merck KGaA operates as a science and technology company in Germany and internationally. It operates through Life Science, Healthcare, and Electronics segments. The Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as the industrial sector. This segment offers science and lab solutions comprising reagents, consumables, devices, instruments, software, and services for research, production, and testing; process solutions consisting of filtration devices, chromatography...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1668
• Employees: 59,020
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: MRK

Financial Performance

In 2024, Merck KGaA's revenue was 21.16 billion, an increase of 0.78% compared to the previous year's 20.99 billion. Earnings were 2.78 billion, a decrease of -1.66%.